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Abstract. Under complete linkage disequilibrium (LD), robust tests
often have greater power than Pearson’s chi-square test and trend
tests for the analysis of case-control genetic association studies. Robust
statistics have been used in candidate-gene and genome-wide associa-
tion studies (GWAS) when the genetic model is unknown. We consider
here a more general incomplete LD model, and examine the impact of
penetrances at the marker locus when the genetic models are defined
at the disease locus. Robust statistics are then reviewed and their ef-
ficiency and robustness are compared through simulations in GWAS
of 300,000 markers under the incomplete LD model. Applications of
several robust tests to the Wellcome Trust Case-Control Consortium
[Nature 447 (2007) 661–678] are presented.
Key words and phrases: Efficiency robustness, genetic models, genome-
wide association studies, linkage disequilibrium, ranking and selection,
incomplete LD model.
1. INTRODUCTION
Genome-wide association studies (GWAS) have
been used to detect true associations between 100,000
to 500,000 genetic markers (single-nucleotide poly-
morphisms—SNPs) and common or complex dis-
eases (e.g., Klein et al., 2005; Sladek et al., 2007;
WTCCC, 2007). Currently, up to a million SNPs
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are used in GWAS. A simple and initial analysis
of GWAS is a genome-wide scan, in which a statis-
tical test is applied to detect association one SNP
at a time. Test statistics and/or their p-values are
obtained for all SNPs and ranked in order of their
statistical significance. After all SNPs are ranked, a
prespecified small proportion of SNPs from the top-
ranked SNPs (or SNPs with p-values less than a pre-
specified genome-wide threshold level) is selected for
further, more focused analyses, for example, haplo-
type analysis, multi-marker analysis, fine mapping,
imputation and independent replication studies (see
Hoh and Ott, 2003; Marchini, Donnelly and Cardon,
2005; Schaid et al., 2005). The genome-wide scan has
also been shown to be cost-effective in two-stage de-
signs for GWAS, in which additional subjects are
genotyped in the second stage for a small portion
of selected SNPs in the first stage (see Elston, Lin
and Zheng, 2007; Thomas et al., 2009). We focus on
robust tests for GWAS in the single stage designs.
Since only a small portion of top-ranked SNPs is
selected in genome-wide scans, it is important that
the probability of at least one SNP with true asso-
ciation being selected is high, for example, greater
than 80% (Zaykin and Zhivotovsky, 2005; Gail et al.,
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2008). The probability that a SNP with true associ-
ation is detected, confirmed and replicated in later
more focused analyses is often smaller. Hence, one of
the goals of genome-wide scans is to rank the SNPs
with true associations as near to the top as pos-
sible. Zaykin and Zhivotovsky (2005) showed that
the factors that mainly affect the rankings of true
SNPs include the total number of SNPs, the number
of SNPs with true associations, the genetic effects
(genotype relative risks or odds ratios), the sample
size, power of the association test used, and linkage
disequilibrium (LD) between SNPs and the func-
tional locus (the true unknown disease locus). Most
of the above factors are determined by the study
design, except the power of the test for association.
The common association tests include Pearson’s chi-
squared test (Pearson’s test, for short), the Cochran-
Armitage trend tests (CATTs) and the allelic test.
Three CATTs are available depending on the under-
lying genetic model (the mode of inheritance of the
disease locus). Common genetic models include re-
cessive, additive, multiplicative and dominant mod-
els. Overdominant and underdominant models may
also be used, but they are less common. The allelic
test has performance similar to that of the CATT
under the additive model when the Hardy–Weinberg
equilibrium proportions hold (Sasieni, 1997; Guedj,
Nuel and Prum, 2008). Thus, the allelic test is not
considered here.
Intuitively, the most powerful test should be used
in genome-wide scans. For common and complex
diseases, it is possible that there are multiple func-
tional loci with different genetic models, in partic-
ular, for GWAS. The power of an association test
depends on the underlying genetic models of the
functional loci, which, however, are unknown. They
could be any of the four common genetic models or
none of them. In addition, imperfect LD between
functional and marker loci can modify the under-
lying genetic model, further increasing uncertainty.
In this case, there is no uniformly most powerful
test for a genome-wide scan. It is known that the
most efficient CATT is available when the genetic
model is known (Sasieni, 1997; Freidlin et al., 2002).
When the genetic model is unknown, using a single
CATT is not robust across a family of genetics mod-
els. Therefore, in this situation, more robust tests
have been proposed for both candidate-gene studies
and genome-wide scans (Freidlin et al., 2002; Sladek
et al., 2007; Zheng and Ng, 2008; Gonzalez et al.,
2008; Joo et al., 2009). The performance of the ro-
bust test statistics has been studied under the per-
fect LD model, that is, the SNP is the same as the
functional locus (see more discussion later). This is,
however, a strong assumption for GWAS. In particu-
lar, when one of the models embedded into a robust
test holds at the functional locus, it remains unmod-
ified at the marker locus. Therefore, it is not surpris-
ing that robust tests based on the maximum of test
statistics over common genetic models often provide
greater power than Pearson’s test and CATTs. How-
ever, when LD is imperfect, the induced penetrance
values at the marker are weighted averages of the
causal penetrances, where the weights are functions
of LD. Thus, the imperfect LD will change certain
models, such as the dominant or the recessive mod-
els, so that the heterozygote penetrance will have an
intermediate value between those for the homozy-
gotes. Therefore, it is important to investigate not
only the exact form of such penetrance modifica-
tions, but also its impact on the performance of the
robust tests for association.
In this article we consider a general LD model
with the standardized LD parameter, D′ (Lewontin,
1964), and study the properties of the penetrances
defined at the marker locus given the genetic model
defined at the functional locus. In addition to re-
viewing some common robust tests for case-control
association studies, we also compare their perfor-
mance under this general model with a varying D′.
Using robust tests when there is imperfect LD has
not been studied perviously. The perfect LD case,
where the marker and the disease loci coincide, can
be obtained as a special case at D′ = 1, with an ad-
ditional requirement of equality of allele frequencies
at the marker and the disease locus. This implies
a perfect correlation between the alleles at the two
loci. Under this general model, we also examine the
effectiveness and robustness of the genetic model se-
lection procedure (Zheng and Ng, 2008). Simulation
studies are conducted to compare the efficiency ro-
bustness of various robust tests under this general
model for genome-wide scans of 300,000 SNPs. Ap-
plications of robust tests are presented using real
data from a GWAS (WTCCC, 2007).
The rest of the article is organized as follows. In
Section 2 we introduce notation, the case-control
data and different genetic models. The
Hardy–Weinberg disequilibrium coefficient and its
use to detect the underlying genetic model is given
in Section 3. Various robust tests for candidate-gene
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analysis and GWAS will be reviewed under the per-
fect LD model in Section 4. Section 5 presents nu-
merical results based on the simulation studies. The
performance of the model selection procedure under
the general LD model will be reported. Compari-
son of several robust tests in analyzing genome-wide
data is also presented. Applications to real data are
given in Section 6. Discussion and conclusions are
given in the final section.
2. GENETIC MODELS
2.1 Notation and Data
Consider a case-control association study with r
cases and s controls and a SNP with alleles A and B.
Denote the population frequencies of the alleles by
Pr(B) = p and Pr(A) = pc = 1− p. The three geno-
types of the SNP are denoted by G0 = AA, G1 =
AB, and G2 = BB, with the population frequen-
cies Pr(Gi) = gi for i = 0,1,2. When the Hardy–
Weinberg equilibrium (HWE) proportions hold in
the population, (g0, g1, g2) = (p
2
c ,2ppc, p
2). The case-
control data for the SNP can be displayed in a 2× 3
contingency table with the rows corresponding to
case or control groups and the columns to the three
genotypes. The genotype counts for (G0,G1,G2) in
cases and controls are denoted by (r0, r1, r2) and
(s0, s1, s2), respectively. The genotype counts follow
multinomial distributions: (r0, r1, r2)∼Mul(r;p0, p1,
p2) and (s0, s1, s2) ∼ Mul(s; q0, q1, q2), where pi =
Pr(Gi|case) and qi = Pr(Gi|control) for i = 0,1,2.
Under the null hypothesis of no association, H0 :pi =
qi for all i.
Denote the penetrance of the SNP by fi =Pr(case|
Gi), and the disease prevalence by k = Pr(case).
Then pi = gifi/k and qi = gi(1− fi)/(1− k). Hence,
the null hypothesis becomes H0 :f0 = f1 = f2 = k.
For simplicity, we assume in this section there is
only one functional locus. Therefore, there is only
one genetic model.
2.2 Perfect LD Model
Under this model, the SNP is also the functional
locus with equal allele frequencies. The penetrances
fi, i= 0,1,2, defined earlier are also penetrances of
the functional locus. Genotype relative risks (GRRs)
are defined by λi = fi/f0 for i = 1,2, where f0 is
the reference penetrance. Under the alternative hy-
pothesis, allele B is the risk allele if the probabil-
ity of having the disease increases with the number
of B alleles in the genotype. That is, f2 ≥ f1 ≥ f0
and f2 > f0. These two constraints define a family
of constrained genetic models, which contains four
commonly used genetic models:
Λ = {(λ1, λ2) :λ2 ≥ λ1 and λ2 > 1}.(1)
We refer to Λ as the constrained space for genetic
models when the risk allele is known. The null hy-
pothesis corresponds to H0 :λ1 = λ2 = 1. The ge-
netic model is recessive if λ1 = 1, additive if λ1 =
(1 + λ2)/2, multiplicative if λ1 = λ
1/2
2 , and domi-
nant if λ1 = λ2. Let λ2 = λ for some λ ≥ 1. Then
λ1 can be calculated using λ value under one of the
four genetic models. The first three letters of each
model are used to indicate the genetic model in the
following, for example, REC stands for the recessive
model.
Note that Λ does not contain overdominant or un-
derdominant models, which occurs when λ1 ≥ λ2 ≥
1, λ1 > 1 and λ2 ≥ 1≥ λ1, λ2 > λ1, respectively. These
two models are less common compared to the other
four genetic models reviewed here.
2.3 Incomplete LD Model
Under this model, the SNP of interest is not the
functional locus. Suppose the functional locus also
has two alleles, denoted by a and b, with the popu-
lation frequencies Pr(b) = q and Pr(a) = qc = 1− q.
Assume that the SNP with alleles A and B is asso-
ciated with the disease through LD with the func-
tional locus with alleles a and b. Table 1 repre-
sents the joint probabilities of the two loci, in which
D =Pr(Aa)−Pr(A)Pr(a) measures LD between the
SNP and the functional locus. When D = 0, they are
in linkage equilibrium. An association between the
SNP and a disease can be established when |D|> 0
and when the two loci are linked.
There are two commonly used measures of the re-
lationship between the SNP and the functional lo-
cus: D′ and the correlation between the alleles A
and a. Denote pAa = Pr(Aa), pAb = Pr(Ab), pBa =
Table 1
Joint probabilities of the marker and functional locus under
incomplete LD model
Functional locus
Marker a b
A pcqc +D pcq−D pc
B pqc −D pq+D p
qc q 1
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Pr(Ba), and pBb = Pr(Bb). Then D = pAapBb −
pAbpBa. The measureD
′ ∈ [−1,1] of Lewontin (1964)
is defined as
D′ =
D
min(qcp, pcq)
, if D> 0;
=
D
min(qcpc, pq)
, if D≤ 0.
When the SNP is identical to the functional locus
(i.e., A ≡ a, B ≡ b and p ≡ q), pBb = p, pAa = pc,
and pAb = pBa = 0. Thus, D
′ = 1. However, D′ = 1
can be reached when the SNP is not identical to the
functional locus (e.g., when p 6= q). The correlation
between the two alleles is defined as (Weir, 1996)
Corr(A,a) =
pAapBb − pAbpBa√
ppcqqc
.
Note that the correlation reaches its maximum value
only when p= q. The LD model is complete if |D′|=
1 and perfect if |Corr(A,a)| = 1. In this article we
assume the two loci have the same allele frequencies.
Thus, D′ and the correlation are equivalent. That is,
in this article the (im)perfect LD model is equivalent
to the (in)complete LD model.
In the simulations we specify D′, p and q. Then,D
can be calculated. Using Table 1, the four haplotype
frequencies pAa, pAb, pBa and pBb can be obtained
by replacing D in Table 1 by D′min(qcp, pcq) when
D ≥ 0 (a similar term is used when D< 0).
The definition of a genetic model under the imper-
fect LD model differs from that under the perfect LD
model. Denote the genotypes at the functional locus
by G∗0 = aa, G
∗
1 = ab and G
∗
2 = bb. The penetrance
of the functional locus is given by f∗i =Pr(case|G∗i )
for i = 0,1,2. Accordingly, define GRRs by λ∗i =
f∗i /f
∗
0 for i= 1,2. The penetrance of the SNP is the
same as before and still denoted by fi. Denote f =
(f0, f1, f2)
t, f∗ = (f∗0 , f
∗
1 , f
∗
2 )
t, where t is transpose
and P∗ = (Pr(G∗i |Gj))3×3 and P = (Pr(Gi|G∗j ))3×3
are 3× 3 transition matrices. Then we have
f =P∗tf∗,(2)
f
∗ =Ptf .(3)
Under the perfect LD model, the two transition ma-
trices are identity matrices P∗ = P = I. The con-
ditional probabilities in (2) can be obtained using
Pr(G∗i |Gj) = Pr(G∗i ,Gj)/
∑2
l=0Pr(G
∗
l ,Gj) under the
Hardy–Weinberg proportions at both SNP and func-
tional locus, which are given in Table 2. Note that
these are functions of the four haplotype frequencies.
The conditional probabilities in (3) can be obtained
similarly, and can also be found in Nielsen and Weir
(1999) and Hanson et al. (2006), Table 3.
2.4 Properties of Genetic Models under the
Imperfect LD Model
We defined genetic models using penetrances (f0,
f1, f2) at the SNP of interest. Under the imper-
fect LD model, the genetic model should be defined
at the functional locus using (f∗0 , f
∗
1 , f
∗
2 ). Thus, the
REC, ADD, MUL or DOM models correspond to
λ∗1 = 1, λ
∗
1 = (λ
∗
2 + 1)/2, λ
∗
1 = λ
∗1/2
2 , or λ
∗
1 = λ
∗
2, re-
spectively. A constrained family of possible genetic
models at the functional locus is given by
Λ∗ = {(λ∗1, λ∗2) :λ∗2 ≥ λ∗1 and λ∗2 > 1}.(4)
Note that Λ and Λ∗ are different under the imperfect
LD model, and they are linked by the two transition
matrices in (2) and (3). Under the imperfect LD
model, applying Table 2 to fi =
∑2
j=0Pr(G
∗
j |Gi)f∗j ,
Table 2
Conditional probabilities in the transition matrix (2)
Pr(G∗i |Gj) Formula
Pr(G∗0|G0) = Pr(aa|AA) p
2
Aa/(p
2
Aa +2pAapAb + p
2
Ab) = F
2
1
Pr(G∗0|G1) = Pr(aa|AB) pAapBa/(pAapBa + pAapBb + pAbpBa + pAbpBb) = F1F2
Pr(G∗0|G2) = Pr(aa|BB) p
2
Ba/(p
2
Ba +2pBapBb + p
2
Bb) = F
2
2
Pr(G∗1|G0) = Pr(ab|AA) 2pAapAb/(p
2
Aa + 2pAapAb + p
2
Ab) = 2F1F3
Pr(G∗1|G1) = Pr(ab|AB) (pAapBb + pAbpBa)/(pAapBa + pAapBb + pAbpBa + pAbpBb) = F1F4 + F2F3
Pr(G∗1|G2) = Pr(ab|BB) 2pBapBb/(p
2
Ba +2pBapBb + p
2
Bb) = 2F2F4
Pr(G∗2|G0) = Pr(bb|AA) p
2
Ab/(p
2
Ab + 2pAapAb + p
2
Ab) = F
2
3
Pr(G∗2|G1) = Pr(bb|AB) pAbpBb/(pAapBa + pAapBb + pAbpBa + pAbpBb) = F3F4
Pr(G∗2|G2) = Pr(bb|BB) p
2
Bb/(p
2
Ba + 2pBapBb + p
2
Bb) = F
2
4
F1 = (pcqc +D)/pc, F2 = (pqc −D)/p, F3 = (pcq−D)/pc, F4 = (pq+D)/p
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we have
f0 = f
∗
0 (F
2
1 +2F1F3λ
∗
1 + F
2
3 λ
∗
2),(5)
f1 = f
∗
0 {F1F2 + (F1F4 + F2F3)λ∗1 +F3F4λ∗2},(6)
f2 = f
∗
0 (F
2
2 +2F2F4λ
∗
1 + F
2
4 λ
∗
2).(7)
The true disease model at the functional locus, de-
fined using (λ∗1, λ
∗
2), is unknown. We study proper-
ties of the penetrances (f0, f1, f2) or GRRs (λ1, λ2)
defined at the SNP given (λ∗1, λ
∗
2).
Theorem 2.1. Under the imperfect LD model
with |D′|< 1, if (λ∗1, λ∗2) ∈Λ∗ at the functional locus,
then (λ1, λ2) ∈Λ at the marker locus. Moreover, for
(λ∗1, λ
∗
2) ∈Λ∗ −{(1,1)}, if λ∗1 = 1 (or λ∗1 = λ∗2), then
λ1 > 1 (or λ2 > λ1).
Proof. Using F2−F1 =−D/(ppc) =−(F4−F3)
and (5) to (7), we obtain
f1− f0 = f
∗
0D
ppc
{F1(λ∗1 − 1) + F3(λ∗2 − λ∗1)},(8)
f2− f1 = f
∗
0D
ppc
{F2(λ∗1 − 1) + F4(λ∗2 − λ∗1)}.(9)
It follows that f2 ≥ f1 ≥ f0 and f2 > f0 when f∗2 ≥
f∗1 ≥ f∗0 and f∗2 > f∗0 . The proof of the second claim
is trivial using the above two expressions and that,
from Table 1, all Fi, i= 1,2,3,4, are positive. 
Theorem 2.1 shows that when the GRRs are con-
strained in Λ∗ at the functional locus, they are also
constrained to a subset of Λ at the SNP when |D′|<
1. In addition, when the true disease model is either
REC or DOM at the functional locus, it is no longer
REC or DOM at the SNP, respectively. They are
“closer” to the ADD/MUL models. The implication
of this finding is that one will not see a pure DOM
or REC model at the marker locus if the constrained
model space Λ∗ is considered at the functional locus.
It also provides a rationale for the genetic model se-
lection approach (Zheng and Ng, 2008) in that an
ADD/MUL is always chosen unless there is strong
evidence to indicate the REC or DOM models.
Even though the REC (or DOM) model at the
functional locus is no longer retained at the SNP
when |D′| < 1, the ADD (or MUL) model is re-
tained. Dividing (8) and (9) by f0, we obtain
2λ1 − 1− λ2 = f
∗
0D
2
f0p2p2c
(2λ∗1 − 1− λ∗2).(10)
Using (5) to (7) to expand λ2−λ21 = (f2f0− f21 )/f20
and (F2F3 − F1F4)2 =D2/(p2p2c), we obtain
λ2 − λ21 =
f∗20 D
2
f20p
2p2c
(λ∗2 − λ∗21 ).(11)
The above two equations lead directly to the follow-
ing result.
Theorem 2.2. Under the imperfect LD model
with |D′|< 1, when the genetic model is ADD (λ∗1 =
(1+ λ∗2)/2) or MUL (λ
∗
2 = λ
∗2
1 ) at the functional lo-
cus, the same model is retained at the marker locus.
Figure 1 displays the mapping of genetic models
from Λ∗ to Λ under the imperfect LD model. If we
still define a genetic model at the marker locus un-
der the imperfect LD model, then, using (3) and a
Fig. 1. Plots of the GRR spaces Λ∗ and λ under the inperfect LD model.
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table similar to Table 2, the REC or DOM models
at the marker locus would correspond to the under-
dominant or overdominant models at the functional
locus, respectively.
3. THE HARDY–WEINBERG
DISEQUILIBRIUM COEFFICIENT AND
GENETIC MODEL SELECTION
The Hardy–Weinberg disequilibrium (HWD) co-
efficient in cases or between cases and controls has
been used to detect association (Nielsen, Ehm and
Weir, 1998; Zaykin and Nielsen, 2000; Song and El-
ston, 2006). In addition, it can also be used to de-
tect the underlying genetic model at the marker lo-
cus (Wittke-Thompson, Pluzhnikov and Cox, 2005;
Zheng and Ng, 2008). In this section we first review
the HWD coefficient and how it can be used to de-
tect the genetic model at the SNP of interest. Then
we study whether it can still be used to detect the
genetic model which is defined at the functional lo-
cus under the imperfect LD model.
Using the notation in Section 1, the HWD coeffi-
cient at the SNP with alleles A and B is given by
(Weir, 1996)
∆ = Pr(AA)− {Pr(AA) + Pr(AB)/2}2
= g2 − (g2 + g1/2)2.
In cases and controls, it is denoted by ∆1 and ∆0,
respectively, and given by
∆1 = p2 − (p2 + p1/2)2 and
∆0 = q2 − (q2 + q1/2)2.
Substituting pi = gifi/k and qi = gi(1− fi)/(1− k)
under the Hardy–Weinberg proportions (∆ = 0), one
has (Wittke-Thompson, Pluzhnikov and Cox, 2005;
Zheng and Ng, 2008)
∆1 =
f20 p
2p2c
k2
(λ2 − λ21),(12)
∆0 =
f20 p
2p2c
(1− k)2 (2λ1 − 1− λ2 − f0λ
2
1 + f0λ2).(13)
Using the signs of (∆1,∆0), Zheng and Ng (2008)
divided Λ in (1) into four mutually exclusive re-
gions R1 to R4. The signs in the four regions are
(∆1,∆0) = (+,−) in R1, (−,−) in R2, (−,−) in R3,
and (−,+) in R4. The REC model belongs to R1
and the DOM model belongs to R4. The region R2 is
bounded by the ADD and MUL models (see Figure 1
of Zheng and Ng, 2008). Therefore, under the REC
model (defined at the SNP with λ1 = 1), ∆1 > 0
and ∆0 < 0, and under the DOM model, ∆1 < 0 and
∆0 > 0. Zheng and Ng (2008) used ∂∆=∆1−∆0 as
a genetic model indicator. The REC model implies
that ∂∆> 0, while the DOM model implies ∂∆< 0.
A normalized test statistic based on ∂̂∆= ∆̂1− ∆̂0,
where p̂i = ri/r and q̂i = si/s, is given
ZHWDTT =
(rs/n)1/2∂̂∆
{1− n2/n− n1/(2n)}{n2/n+ n1/(2n)}
∼N(0,1)
under H0 and referred to as the HWD trend test
(HWDTT) (Song and Elston, 2006). It is used to
select a genetic model (Zheng and Ng, 2008). Given
that B is the risk allele, the ADD (or MUL) model
is chosen unless there is strong evidence to indicate
a REC model or a DOM model. When ZHWDTT >
1.645, the REC model is selected; when ZHWDTT <
−1.645, the DOM model is selected.
Under the imperfect LD model, using (11) and
(10), (12) and (13) can be written as
∆1 =
f∗20 D
2
k2
(λ∗2 − λ∗21 ),
∆0 =
f0f
∗
0D
2
(1− k)2 (2λ
∗
1 − 1− λ∗2 − f∗0λ∗21 + f∗0λ∗2).
Comparing the above (∆1,∆0) with (12) and (13),
we see that the signs of (∆1,∆0) do not change when
the genetic model is defined at the functional locus.
Hence, the model selection procedure of Zheng and
Ng (2008) can still be used.
4. ROBUST TESTS
4.1 Pearson’s Test and CATTs
Given the case-control data for a single SNP, (r0,
r1, r2) and (s0, s1, s2), denote ni = ri + si for i =
0,1,2 and n = n0 + n1 + n2. Pearson’s test can be
written as
Tχ2 =
2∑
i=0
(ri − nir/n)2/(nir/n)
+
2∑
i=0
(si − nis/n)2/(nis/n),
which asymptotically follows a chi-squared distribu-
tion with 2 degrees of freedom (df) under H0. The
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CATT with a score x ∈ [0,1] is given by
Zx = n
1/2
(
n
2∑
j=0
xjrj − r
2∑
j=0
xjnj
)
/
[rs{n(n1 +4n2)− (n1 + 2n2)2}]1/2,
where (x0, x1, x2) = (0, x,1). Under H0, Zx asymp-
totically follows the standard normal distribution
N(0,1) for a given x. Optimal scores for REC,
ADD/MUL and DOM models are x= 0,1/2 and 1.
When the genetic model is unknown, Z1/2 is often
used. There is a trade-off between Tχ2 and Zx with
x= 1/2. Pearson’s test is more robust but less pow-
erful, in particular, under the ADD or DOM models,
while the trend test is more powerful under the ADD
or DOM models but less robust when the score x is
misspecified. Pearson’s test is identical to the trend
test Z2x with x = (r1/n1 − r0/n0)/(s1/n1 − s0/n0)
(Yamada and Okada, 2009; Zheng, Joo and Yang,
2009). In practice, however, x is prespecified. Thus,
this condition is rarely satisfied.
4.2 MAX
To avoid the trade-off between Pearson’s test and
the CATT, one approach is to consider maximum
tests. A typical maximum test is given by (Freidlin
et al., 2002; Sladek et al., 2007)
MAX3 =max{|Z0|, |Z1/2|, |Z1|}.
Other versions of maximum tests are also used, for
example, MAX= supx∈[0,1] |Zx| (Davies, 1977, 1987),
the maximum of three likelihood ratio tests under
various genetic models (Gonza´lez et al., 2008), and
for a quantitative trait (Lettre, Lange and Hirschhorn,
2007).
Computational aspects of maximum tests have been
discussed by Conneely and Boehnke (2007) and Li et
al. (2008a). The empirical distribution of MAX3 can
be obtained from simulation using the joint multi-
variate normal distribution of the CATTs consider-
ing asymptotic null correlations among them (Frei-
dlin et al., 2002) or from a parametric bootstrap pro-
cedure by generating data using (r0, r1, r2) ∼
Mul(r; p̂0, p̂1, p̂2) and (s0, s1, s2) ∼Mul(s; p̂0, p̂1, p̂2),
where p̂i = ni/n. A simpler algorithm to find the
asymptotic and empirical null distributions of MAX3
is recently proposed (Zang, Fung and Zheng, 2010).
The asymptotic null distribution of MAX3 is a func-
tion of the minor allele frequency (MAF) of the SNP.
In a genome-wide scan to rank a large number of
SNPs, Li et al. (2008b) demonstrated that ranking
can be done easily by the values of MAX3 rather
than by their p-values. Hence, there is no need to
calculate the p-values of MAX3, even though the p-
values of MAX3 are more comparable across SNPs.
4.3 MIN2
An alternative approach used by WTCCC (2007)
utilizes both Pearson’s test and the CATT Z1/2.
WTCCC (2007) proposed to use the minimum of
the p-values of Tχ2 and Z1/2 to scan all the SNPs.
SNPs with the minimum p-value less than a thresh-
old level were retained for further analyses. Joo et
al. (2009) denoted the minimum of the two p-values
by
MIN2 =min{pTχ2 , pZ1/2}
and obtained its asymptotic null distribution and its
p-value, denoted by pMIN2. The key formula to find
the distribution and p-value for MIN2 is the joint
distribution of Pearson’s test and Z1/2 under H0,
which is given by (Joo et al., 2009)
Pr(Z21/2 < t1, Tχ2 < t2)
= 1− 1
2
e−t1/2 − 1/2e−t2/2
+
1
2pi
∫ t2
t1
e−v/2 arcsin
(
2t1
v
− 1
)
dv,
when t1 < t2, and Pr(Z
2
1/2 < t1, Tχ2 < t2) = 1 −
exp(−t2/2) when t1 > t2. Unlike MAX3, the asymp-
totic null distribution of MIN2 does not depend on
the MAFs of SNPs. Hence, MIN2 itself can be used
to rank all SNPs, which results in the same ranks as
when the p-value of MIN2 is used. Joo et al. (2009)
demonstrated that pMIN2 >MIN2, because Z
2
1/2 and
Tχ2 are correlated under the alternative hypothesis.
Thus, MIN2 itself cannot be used as the p-value.
4.4 The Genetic Model Selection (GMS)
Procedure
The GMS procedure is an adaptive approach. It
contains two phases. In phase 1 the underlying ge-
netic model is detected using the value and sign of
ZHWDTT (Song and Elston, 2006; see also Section
3). Once the model is selected (REC, ADD/MUL
or DOM), in the second phase, the CATT optimal
for the selected model is applied to test for asso-
ciation. For example, if the REC model is selected
using the HWDTT, Z0 would be used in phase 2 to
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test for association. Since the analyses in the two
phases are correlated, Zheng and Ng (2008) derived
the asymptotic null correlation for the GMS. This
correlation is incorporated in the distribution of the
test statistics to control for the Type I error. Like
MIN2, computing the p-value of the GMS requires
integrations. Like MAX3, the GMS can be used to
rank SNPs (Zheng et al., 2009). Using test statistics
to directly rank SNPs is easier than using p-values
of the GMS. Since the GMS depends on which allele
is the risk allele or whether the minor allele is the
risk allele, for each SNP, we first determine the risk
allele (B is risk allele if Z1/2 > 0). If the risk allele is
B, then the above GMS can be applied. Otherwise,
we can switch the two alleles and apply the above
GMS.
4.5 Other Tests
Balding (2006) provided an excellent review of
statistical methods for the analysis of association
studies. Two other robust two-phase tests are also
available that we do not include here. One feature
of these methods is that the test statistics in two
phases are asymptotically independent under H0
(Zheng, Song and Elston, 2007, Zheng et al., 2008).
In this case, the second phase can be used as a “self-
replication,” an idea proposed in van Steen et al.
(2005). Alternatively, the significance level α can be
decomposed to (α1, α2) such that α1α2 = α, where
α1 is used for the phase 1 analysis and α2 for the
phase 2 analysis. The null hypothesis is rejected
when analyses in both phases are significant at their
corresponding levels. Choices of α1 and α2 with α1α=
α in GWAS were discussed in Zheng, Song and El-
ston (2007), Zheng et al. (2008). Another robust
test is the constrained likelihood ratio test (LRT)
(Wang and Sheffield, 2005). It is similar to the LRT
except that the alternative space is restricted to
Λ − {(1,1)}. The performance of the constrained
LRT is similar to that of MAX3 described above.
Thus, we only consider MAX3 here.
4.6 Why Robust Tests?
One of the reasons that we use robust tests in
GWAS is that there might be multiple functional
loci for a given disease. The modes of inheritance or
genetic models may differ from one functional locus
to the other. Another reason for using robust tests
is the distortion of the actual genetic model at the
marker locus due to incomplete LD, which further
amplifies uncertainty about the model. Thus, robust
tests are generally preferred. We use efficiency ro-
bustness to measure robustness (Gastwirth, 1985).
A test T1 is said to have greater efficiency robust-
ness than a test T2 if the worst asymptotic relative
efficiency of T1 to the asymptotically optimal test
across all genetic models is higher than the worst
asymptotic relative efficiency of T2. The CATT Z1/2
optimal for the ADD model is most robust among all
trend tests when the genetic models are constrained
in Λ. Pearson’s test is also robust because it does not
require the genetic models to be constrained or the
alternative hypothesis to be ordered. When restrict-
ing to Λ, tests more robust than Z1/2 are available.
MAX3 and GMS are two examples. They both have
greater efficiency robustness than Pearson’s test and
Z1/2 (Freidlin et al., 2002; Zheng and Ng, 2008).
On the other hand, combining information of both
Pearson’s test and Z1/2, MIN2 is also more efficiency
robust than either Pearson’s test or Z1/2. Three ro-
bust tests, MAX3, GMS and MIN2, appear to have
comparable efficiency robustness in candidate-gene
studies (Joo et al., 2009).
In genome-wide scans it is desirable to locate the
SNPs representing true association as near the top
as possible, where all SNPs compete for the top
ranks. Under the complete LD model, Zheng et al.
(2009) conducted simulation studies comparing the
three robust methods in ranking 300,000 SNPs,
among which there were 6 functional loci with dif-
ferent genetic models, MAFs and GRRs (from 1.25
to 1.5). The results showed that the GMS slightly
outperforms MIN2 and MAX3 when the top 5000
SNPs were selected. The criteria used for compari-
son included the probability that the top 5000 SNPs
contained at least one SNP with true association, as
well as the minimum and average ranks of SNPs
with true associations among the top 5000 SNPs.
We will conduct similar simulation studies in Sec-
tion 5 under the inperfect LD model. The reason
that we choose the top 5000 SNPs rather than a
smaller number, say, the top 100, is that the SNPs
with true association are not always ranked near
the top, especially for a small GRR between 1.2 and
1.5 and small sample sizes (Zaykin and Zhivotovsky,
2005). If we examine the top 100 list with 250 cases
and 250 controls (the sample sizes that we used in
our simulation studies), the probability that the list
of the top 100 SNPs contains a true association is
less than 0.50.
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5. SIMULATION STUDIES
5.1 The GMS Procedure under the Imperfect
LD Model
We first conducted simulation studies to estimate
the distribution of genetic models selected by the
GMS. We chose disease prevalence k = 0.1 and GRR
λ∗2 = 2 at the functional locus. Then λ
∗
1 was obtained
using λ∗2 and a given genetic model at the functional
locus. We considered 0.1, 0.3 and 0.5 for the equal
MAFs at a SNP (p) and a functional locus (q). This
allows us to compare the frequencies of the different
models selected when D′ = 1.0, 0.8 and 0.6. With
equal allele frequencies p = q, Corr(A,a) = D′. In
each of 10,000 replicates, 250 cases and 250 con-
trols were simulated from multinomial distributions
in which the penetrances at a SNP were calculated
using (5) to (7). When the GMS did not select REC
or DOM, the ADD or MUL models are used and de-
noted here by A/M. Results are reported in Table
3.
When the true model is REC or DOM at the
functional locus, the frequencies that the model se-
lected by the GMS at the marker locus is REC
or DOM decreases dramatically when D′ becomes
small. For example, when p= q = 0.3, the frequency
of selecting REC at the marker locus is about 67.5%
when the true model at the functional locus is REC,
and D′ = 1. This frequency declines to 18.6% when
D′ = 0.6. These frequencies, however, are not sensi-
tive when the true model at the functional locus
is either ADD or MUL. The findings are consis-
tent with Theorems 2.1 and 2.2. Given the genetic
model space Λ∗ at the functional locus, the genetic
model space at the marker locus Λ is shifted to-
ward the center of the space Λ∗ corresponding to
the ADD/MUL models.
Table 4 reported the GRRs at the marker locus
given those at the functional locus. Note that when
Table 4
GRRs (λ1, λ2) at a SNP given GRR λ
∗
2 = 2 at the functional
locus: p= q = 0.3. When D′ = 1, λ∗i = λi for i= 1,2
D′/(λ1, λ2)
True
model 1.0 0.8 0.6
REC (1.00, 2.00) (1.05, 1.73) (1.07, 1.50)
ADD (1.50, 2.00) (1.38, 1.75) (1.27, 1.54)
MUL (1.41, 2.00) (1.22, 1.48) (1.24, 1.53)
DOM (2.00, 2.00) (1.67, 1.77) (1.43, 1.57)
the true model is ADD (λ∗1 = (1 + λ
∗
2)/2) or MUL
(λ∗21 = λ
∗
2), the GRRs at the marker locus follow
the same models. However, λi are smaller than λ
∗
i .
Similar patterns are observed when the true model
is REC or DOM, except that λ1 is slightly greater
than λ∗1 under the REC model.
5.2 Comparison of Robust Tests in GWAS under
the Imperfect LD Model
In Table 3 when the true model is REC or DOM
at the functional locus, the GMS could not select
REC or DOM at the marker locus. This, however,
does not mean that the GMS cannot improve power
or chances of true discoveries when |Corr(A,a)|< 1.
On the contrary, owing to the shrinkage of the ge-
netic model space and that the GMS only selects a
model at the marker locus, it can be viewed as select-
ing an appropriately induced model at the marker
locus. Our next simulation will examine the per-
formance of robust tests under the imperfect LD
model. The simulation procedure follows the one
used in Zheng et al. (2009). We simulated geno-
type counts for each of 300,000 SNPs, among which
6 SNPs have true associations and D′ = 0.8 with
MAF of 0.2 at the functional loci. When D′ = 1,
the number of functional loci is also 6. However,
when D′ = 0.8, we assume the number of functional
loci equals the number of different genetic models in
the simulation. Zheng et al. (2009) considered the
perfect LD model that corresponds to |D′| = 1 or
|Corr(A,a)|= 1. Their results are repeated here for
comparison. The MAFs of 6 true SNPs from the
genetic models listed in the titles of Tables 5 and
6 were 0.1821, 0.2943, 0.1078, 0.4459, 0.1620 and
0.1825. These are also given in Zheng et al. (2009)
and in Li et al. (2008b). MAFs for the rest of the
null SNPs were simulated from a uniform distribu-
tion U(0.1,0.5). The GRRs for the functional loci
were all 1.25 (or 1.50). We applied five robust tests
(Z1/2, Pearson’s test Tχ2 , GMS, MIN2 and MAX3)
to rank all SNPs and the top 5000 SNPs were se-
lected from each of 200 replicates. The criteria to
compare the performance of robust tests include the
probability (prob %) of at least one true SNP be-
ing selected among the top 5000 SNPs, the average
number of true SNPs among the top, and the mean
of the minimum ranks of the true SNPs among the
top. The results are presented in Table 5 (2 REC,
1 ADD, 1 MUL and 2 DOM SNPs) and Table 6 (1
REC, 2 ADD, 2 MUL and 1 DOM SNPs).
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Table 3
Distributions of genetic models selected by the GMS using the HWDTT (%): Disease prevalence k = 0.1, the GRR at the
functional locus λ∗2 = 2 with 250 cases and 250 controls and 10,000 replicates
D′/selected models (A/M = ADD/MUL)
1.0 0.8 0.6
MAF
p= q
True
model REC A/M DOM REC A/M DOM REC A/M DOM
0.1 REC 23.3 76.3 0.4 14.6 84.4 1.0 3.0 90.6 6.4
ADD 2.6 88.9 8.5 2.4 90.2 7.4 2.9 90.8 6.3
MUL 3.4 90.3 6.3 3.7 91.1 5.2 3.8 90.8 5.4
DOM 0.1 60.1 39.8 0.3 76.1 23.6 1.0 84.8 14.2
0.3 REC 67.5 32.5 0.0 39.4 60.4 0.2 18.6 80.6 0.8
ADD 2.2 88.9 8.9 3.1 89.3 7.6 3.7 89.6 6.7
MUL 4.8 90.7 4.5 5.0 90.4 4.6 5.2 90.1 4.7
DOM 0.0 32.8 67.2 0.1 61.4 38.5 0.7 80.2 19.1
0.5 REC 66.0 34.0 0.0 36.8 63.1 0.2 18.3 80.9 0.8
ADD 2.6 89.0 8.4 3.3 89.6 7.1 3.7 90.8 5.5
MUL 5.4 89.9 4.7 5.0 90.1 4.9 5.2 89.9 4.9
DOM 0.0 36.2 63.8 0.1 63.9 36.0 0.8 81.2 18.0
First, when D′ = 1 (Zheng et al., 2009), the GMS
outperforms other tests under all three criteria, while
Pearson’s test had the worst performance. When
D′ = 0.8, however, the GMS and Z1/2 had simi-
lar performances, which together outperform other
tests using the three criteria. This finding is consis-
tent to our results in Theorems 2.1 and 2.2 about
the genetic models under the imperfect LD model.
6. APPLICATIONS TO WTCCC DATA
We apply the five robust tests to a genome-wide
scan using more than 300,000 SNPs after quality
control. The study was originally conducted by
WTCCC (2007) for seven diseases (type 1 diabetes—
T1D, type 2 diabetes—T2D, coronary heart disease—
CHD, hypertension—HT, bipolar disorder—BD,
rheumatoid arthritis—RA and Crohn’s disease—CD).
About 2000 cases were used for each disease and
3000 controls were shared for the seven diseases.
WTCCC (2007) used MIN2 to test for association
after the quality control. They obtained two tables
presenting SNPs with strong associations with
MIN2 < 5 × 10−7 (Table 3 of WTCCC, 2007) and
SNPs with moderate associations with 5 × 10−7 ≤
MIN2 < 5 × 10−5 (Table 4 of WTCCC, 2007). We
reanalyze these data by ranking all SNPs after our
quality control. The goal of this application is to
demonstrate the efficiency robustness of different
test statistics, not to find SNPs with associations
that were not reported in WTCCC (2007).
In our application, for each of the seven diseases,
we rank all SNPs after quality control (398,092 SNPs)
using the five robust tests and report the ranks of
the SNPs that were reported to have strong asso-
ciations in WTCCC (2007), Table 3. Note that we
do not know D′ in reality, nor do we know the num-
ber of functional loci and their modes of inheritance.
Our results are reported in Table 7. The results show
that SNPs with strong associations are all ranked on
the top 5000 SNPs. The CATT is least robust among
the five robust tests as shown by the rank 269 for
BD, while the ranks by the other methods are less
than 25. The GMS tends to have smaller ranks than
MAX3, and MIN2 tends to have ranks between the
CATT and Pearson’s test, which often have higher
ranks than the GMS.
We also studied the ranks of SNPs with moderate
associations reported in WTCCC (2007), Table 4.
The detailed results are not shown here, but summa-
rized below. Similar patterns are also observed, al-
though, for several SNPs, the CATT has large ranks.
For example, for BD, the CATT has rank 147,769 for
SNP rs6458307 on chromosome 6, while the ranks of
other tests for this SNP are less than 150. For T2D,
the CATT has rank 197,064 for SNP rs358806 on
chromosome 3, while the other tests have ranks less
than 100. All ranks of SNPs with either strong or
moderate associations are less than 5000, and only
one SNP (rs17166496 for T1D on chromosome 5)
is ranked more than 5000 by MAX3 and the GMS.
The actual ranks for this SNP are 5521 for the GMS
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Table 5
Genome-wide scans of 300,000 SNPs containing 6 true SNPs (2 REC, 1 ADD, 1 MUL and 2 DOM). Only the top 5000
SNPs are selected. The results are based on 200 replicates: MAF q = 0.2 at the functional locus when D′ = 0.8. Samples sizes
are r = s= 1000 for GRR=1.25 and r = s= 500 for GRR=1.5
D′ = 1.0 D′ = 0.8
GRR
λ2
Robust
tests Prob
Ave. no. of
true SNPs
Mean of
min ranks Prob
Ave. no. of
true SNPs
Mean of
min ranks
1.25 Z1/2 92.0 1.79 971 58.5 1.29 1625
GMS 94.5 1.90 838 56.0 1.29 1488
MAX3 90.5 1.80 909 48.0 1.28 1435
MIN2 89.5 1.79 934 51.0 1.25 1550
Tχ2 86.5 1.69 960 46.5 1.22 1680
1.50 Z1/2 99.5 2.71 186 83.0 1.49 1041
GMS 100.0 2.99 178 85.0 1.54 1111
MAX3 99.5 2.83 205 80.0 1.48 1183
MIN2 100.0 2.78 234 80.0 1.50 1113
Tχ2 100.0 2.71 286 75.0 1.46 1244
and 6063 for MAX3, 652 for Pearson’s test, 724
for MIN2, but 245,454 for the CATT. The under-
lying genetic model for this SNP could be outside
of the constrained genetic model that we considered
here, for example, overdominant or underdominant
for which it is known that Pearson’s test is robust
(Zheng, Joo and Yang, 2009; Joo et al., 2009). In
addition, we found that for those SNPs with small
ranks based on Pearson’s test, a large rank using
the CATT is always accompanied by a large value
of the HWDTT. This is due to the orthogonal de-
composition of Pearson’s test to the HWDTT and
Z21/2 (Zheng et al., 2008). It is also interesting to
note that, even if a SNP has a rank smaller than
those SNPs listed in Table 7, it does not mean the
SNP has a true association with a disease. That is,
in GWAS, a SNP with smaller p-value does not nec-
essarily mean it has stronger association. In fact,
many of these SNPs with smaller ranks have not
been confirmed to have true associations (WTCCC,
2007). This is because a very small number of SNPs
(<100 SNPs) are associated with a disease in GWAS
compared to the number of null SNPs (more than
300,000 SNPs). Therefore, the probability that test
statistics of some null SNPs are greater than those
of all the associated SNPs is high (Zaykin and Zhiv-
otovsky, 2005).
Table 6
Genome-wide scans of 300,000 SNPs containing 6 true SNPs (1 REC, 2 ADD, 2 MUL and 1 DOM). Only the top 5000
SNPs are selected. The results are based on 200 replicates: MAF q = 0.2 at the functional locus and D′ = 0.8. Samples sizes
are r = s= 1000 for GRR=1.25 and r = s= 500 for GRR=1.5
D′ = 1.0 D′ = 0.8
GRR
λ2
Robust
tests Prob
Ave. no. of
true SNPs
Mean of
min ranks Prob
Ave. no. of
true SNPs
Mean of
min ranks
1.25 Z1/2 88.0 1.72 897 49.5 1.31 1564
GMS 87.0 1.79 797 53.5 1.27 1630
MAX3 82.5 1.64 846 47.0 1.24 1702
MIN2 86.0 1.66 932 48.5 1.25 1899
Tχ2 83.0 1.50 1030 41.5 1.20 1847
1.50 Z1/2 99.0 2.46 349 76.5 1.48 1083
GMS 99.5 2.61 355 76.0 1.47 1005
MAX3 98.0 2.34 379 73.0 1.40 1103
MIN2 99.5 2.35 434 74.0 1.38 1105
Tχ2 97.0 2.21 485 66.5 1.31 1179
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Table 7
Ranks of SNPs with strong association of seven diseases in WTCCC (2007), Table 3
Disease SNP ID chrom Z1/2 Tχ2 GMS MAX3 MIN2
BD rs420259 16 269 22 19 20 23
CAD rs1333049 9 9 25 24 24 25
CD rs11805303 1 14 28 23 24 24
rs10210302 2 6 15 15 16 15
rs9858542 3 102 58 58 61 75
rs17234657 5 11 25 19 20 21
rs1000113 5 72 92 78 82 84
rs10761659 10 89 115 100 107 101
rs10883365 10 50 65 59 62 61
rs17221417 16 25 37 35 37 38
rs2542151 18 69 84 77 80 81
RA rs6679677 1 50 72 71 69 70
rs6457617 6 5 13 8 8 13
T1D rs6679677 1 129 137 133 136 135
rs9272346 6 3 6 5 5 5
rs11171739 12 339 361 342 357 354
rs17696736 12 233 245 238 243 242
rs12708716 16 521 534 517 534 530
T2D rs9465871 6 31 41 49 44 45
rs4506565 10 10 17 17 17 16
rs9939609 16 24 38 36 36 37
7. DISCUSSION
We studied some robust tests for case-control ge-
netic association studies. This approach stems from
the classical robust procedures studied in the 1970s
which focused on the estimation of the location pa-
rameter of a symmetric distribution. For a given
family of underlying distributions (or, here, genetic
models), an estimate with a high (low) minimum
correlation, say, >0.80 (<0.50) with the optimal pro-
cedure, indicates a greater (smaller) efficiency ro-
bustness. In early work, the underlying distribution
was assumed to range from the normal distribution
to the Cauchy distribution (Tukey, 1965 and An-
drews et al., 1965). For this family of t-distributions,
the robust estimate of the location parameter was
considered, because within the family of distribu-
tions considered, it had minimum correlation with
the optimal procedure of about 0.60 (Gastwirth,
1966). In case-control genetic association studies,
when the true genetic model is unknown and ranges
from the REC to the DOM models, the minimum
correlation of any two CATTs is about 0.30 (Frei-
dlin et al., 2002). This indicates that using a single
CATT for association is not robust, and tests that
are robust across a family of plausible genetic mod-
els are preferred.
Previous studies of robustness properties of test
statistics for the analysis of case-control genetic as-
sociation studies have been focused on the perfect
(or complete) LD model, that is, the genetic marker
(SNP) is also the functional locus. In this article
we studied genetic models under a general imper-
fect (or incomplete) LD model with linkage disequi-
librium between linked marker locus and functional
locus. The perfect LD model is a special case. Un-
der the imperfect LD model, we found that a ge-
netic model defined by the genotype relative risks
at the functional locus usually no longer remains
the same genetic model at the marker locus, except
for the additive or multiplicative models. The ge-
netic model space at the marker locus is a subset
of that at the functional locus, resulting in smaller
genotype relative risks at the marker than at the
functional locus. The power to detect a true associ-
ation is reduced when the linkage disequilibrium de-
creases, while the model uncertainty increases, com-
plicating the choice of a single association statistic.
Robust tests are shown to perform optimally in this
situation.
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We also review some common efficiency robust
tests for case-control genetic associations and their
usage in genome-wide scans. In genome-wide scans,
all SNPs are ranked by a test statistic or its p-
value (if the p-value is readily obtained) and the top-
ranked SNPs are selected for further analyses. Alter-
natively, as in WTCCC (2007), some genome-wide
threshold levels can be also used to select SNPs.
Multiple testing is an important issue in GWAS
not only because one tests 300,000 up to a million
SNPs, but also because multiple tests are available
for each SNP (and there is no uniform most powerful
test in GWAS). Correcting for multiple testing re-
mains challenging in the analysis of GWAS (Roeder
and Wasserman, 2009), and the need for indepen-
dent replication studies (Kraft, Zeggini and Ioanni-
dis, 2009) and proper meta-analysis (Pfeiffer, Gail
and Pee, 2009) cannot be overemphasized.
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